i2c Pharmaceutical Services built Fast2Clinic™, an integrated inhalation development pathway supporting rapid small-scale clinical manufacture for Phase I studies followed by next-day release.

i2c pharmaceutical services is a leading independent service provider to global pharma, medical technology and emerging companies for the development of inhaled formulations and efficient devices. i2c provides bespoke integrated services from ab initio development through to clinical trials.